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I. INTRODUCTION 
 In recent years, long-term survival of solid organ transplant recipients (SOTRs) has 
improved significantly
1,2
.  In 2008, roughly 223,000 organ transplant recipients were alive in the 
United States.  Due to the effects of long-term immunosuppressive therapy required to prevent 
transplant rejection, SOTRs are at extremely elevated risk of developing non-melanoma skin 
cancer (NMSC), which includes squamous cell carcinoma (SCC) and basal cell carcinoma 
(BCC).   
 Cutaneous SCC is the most common cancer to develop after transplant, with an incidence 
65-250 fold higher than sex- and age-matched controls
3-6
.  SOTRs also have a 10-fold increased 
risk of developing BCCs
3,6
.  The risk of melanoma in SOTRs is unclear.  Some studies have 
found a 2-8 times greater risk of developing melanoma compared to the general population
6,7
 and 
other studies have found no increased risk
8
.  The median time to development of NMSC in 
transplant patients is typically 4-9 years
3,9,10
.    
 The high prevalence of skin cancer among SOTRs is not the only challenge.  SCCs that 
develop in transplant patients are more likely to be exceptionally invasive than those in the 
general population
11-13
.  They are also more likely to metastasize, with approximately 7% of 
cutaneous SCCs in transplant patients becoming metastatic
14
.  Additionally, SOTRs are at risk of 
developing field cancerization, a condition in which a region of skin shows multiple 
precancerous or cancerous changes
15
.    
 Among SOTRs, some patients are at the highest risk for developing skin cancers.  Those 
who have had a previous NMSC are 49 times more likely to develop a subsequent NMSC 
compared to patients who have never had one
16
.  Patients with fair complexions and blue eyes 
are at higher risk of developing NMSC than patients with darker complexions, and risk increases 




.  Duration, type, and intensity of immunosuppression significantly affect skin cancer 
risk and may not be modifiable
18
.   
 Sun exposure is a particularly important risk factor because of its modifiable nature.  
Cumulative lifetime sun exposure, sun exposure before transplantation
17,19
, and long-lasting 
recreational sun exposure have been strongly associated with development of NMSC in 
SOTRs
20
.  In a 24-month prospective matched control study, regular use of sunscreens and sun-
protective clothing appeared to be effective in reducing the number of new NMSCs and actinic 
keratoses, SCC precursor lesions
21
.  While this is extremely promising, in order for such 
strategies to be effective in preventing skin cancers, transplant recipients must recognize the need 
for sun-protective behaviors and understand how to engage in them.   
 Multiple surveys have identified deficits in transplant patients’ knowledge of skin cancer 
risk and prevention.  In a survey of 122 organ transplant patients in Hershey, PA, 50% said they 
did not know immunosuppressant medications put them at elevated risk of skin problems and 
41% did not recall learning about the increased risk of skin cancer after transplantation
22
.  
Another survey of 200 transplant recipients in New York found that only 22% of respondents 
thought they were at higher risk for developing skin cancer than the general public
23
.   
 Even if patients know about their elevated risk of skin cancer and recognize what 
protective behaviors can be effective in reducing their risk, other factors such as motivation and 
attitudes towards sun-protective behaviors may be important in determining whether they engage 
in those protective behaviors.  In the same survey of 200 transplant recipients in New York, 81% 
of respondents reported they believed people look “healthier” with a tan, compared to 64% of the 
US public
23
.   
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 Regular skin examination is another strategy that may prevent skin cancer morbidity and 
mortality in transplant patients.  By allowing early detection and removal of cancers, skin 
examinations may help reduce the risk of metastasis or the likelihood of disfigurement from 
invasive treatments.  The American Academy of Dermatology recommends that all transplant 
patients undergo regular skin screening examinations including skin self-examinations and at 
least yearly total body skin examinations by a healthcare provider
24
.  SOTRs with extensive sun 
damage, precancerous lesions, or skin cancer should be seen more frequently
15
.   
 In order to improve skin cancer prevention and promote early detection of skin cancers 
among transplant patients at the University of North Carolina, I conducted a series of interviews 
with dermatologists and transplant clinic staff to identify areas for potential improvement.  
Through these interviews, I identified several areas of need including: a streamlined dermatology 
referral process, clear guidelines about what education SOTRs should receive, additional written 
information about skin cancer risk for patients, and a risk assessment tool to quickly determine 
which patients are at the highest risk of developing skin cancer.   
 Based on the results of this formative research, the Skin Cancer Prevention Initiative 
(SCPI) program and evaluation plan was developed with the goal of improving skin cancer 
prevention and management for UNC’s transplant patients through collaborations between the 
dermatology department and various transplant clinics.  Key components of the program include 
addressing needs identified through formative research and incorporating educational 
interventions that have been successful in other similar programs.   
 The first section of this paper is a systematic review of the literature to identify existing 
skin cancer prevention programs with components that could be feasibly implemented within the 
SCPI.  Review of these programs helped to identify which strategies appeared most effective at 
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promoting sun protective behaviors.  The second section of this paper consists of the SCPI 
program plan.  The program plan addresses the context, relevant theories, and goals of the 
program as well as a logic model, implementation plan, and budget.  The third section is the 
evaluation plan, which includes information about how and why the program should be assessed.  
The paper concludes with a discussion of program significance and future directions. 
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II. SYSTEMATIC REVIEW 
Introduction 
In order to build on the experiences of previous programs, I used a systematic search 
strategy to identify published programs with similar characteristics to the Skin Cancer Prevention 
Initiative.  I then summarized and analyzed programs that met inclusion criteria (i.e. were highly 
relevant to this project) to determine what aspects of those programs would be best for inclusion 
or exclusion into the SCPI.   
Methods 
The primary research question of this search strategy was: What programs geared toward 
promoting sun protective behaviors or skin self-examination have been previously implemented 
and evaluated?  After conducting a preliminary literature search to identify key terms to use, I 
searched MEDLINE using the following search terms:  "Health education"[mesh] AND ("skin 
neoplasms"[mesh] OR sunscreen OR sun[title]) AND (intervention OR program OR evaluation).  
The search was limited to English language articles and articles published from the beginning of 
MEDLINE to March 1, 2013.  Reviews and letters to the editor were excluded because the 
purpose was to assess original publications about relevant programs.  One-hundred and fifteen 
articles were initially generated.  I also searched reference lists and abstracts of relevant articles 
to identify additional relevant material.   
For a program to be deemed sufficiently similar to SCPI and relevant for this review, the 
following were required (a) target population must be adults, preferably middle-aged or older 
and including both men and women (b) primary goal is increasing use of sun-protective 
behaviors with an ultimate goal of reducing individuals’ risk of skin cancer, (c) intervention 
could be feasibly implemented in a health care-based setting, (d) program evaluation results were 
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available, and (e) the primary purpose of the article must be to describe the program and its 
evaluation.  Articles about skin self-examination (SSE) promotion were excluded if they focused 
primarily on melanoma but not other types of skin cancer.  The target population was not limited 
to transplant patients since skin prevention education programs effective in other adults are likely 
to also be effective in transplant recipients.  After conducting the search strategy and applying 
the inclusion and exclusion criteria, I identified the six most relevant programs. 
Summary of Programs 
Project SUNWISE 
 Project SUNWISE is a program piloted by the United States Postal Service in Southern 
California with the goal of promoting regular occupational use of wide brim hats and sunscreen 
with a SPF of 15 or higher among postal workers
25
.  Postal workers are at high risk for skin 
cancer, as evidenced by the demographics of those participating in the study.  On average, they 
reported spending nearly 4 hours per day in the sun, and roughly 50% had had a previous skin 
cancer.   
 Project SUNWISE was grounded in several theories.  The ecological model that 
emphasizes the roles of environment and policy was a primary component
26
.  Key constructs 
from operant models emphasizing reinforcement and environmental prompts for changing 
behavior were used.  Additionally, Social Learning Theory’s constructs of modeling, social 
influence, reciprocal determinism, and self-efficacy were also used to design the program.   
Particular components of the program included providing postal workers with free wide 
brim hats, stocking locker rooms with large pump bottles of SPF 30 sunscreen, providing letter 
carriers with small bottles to carry sunscreen with them, and delivering six short educational 
messages (to create opportunities for modeling and social influence) about sun protective 
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behaviors over the course of the two year intervention.  Project SUNWISE staff also distributed 
water bottles, key chains, etc. with sun safety messages.  Sun safety questions with answers were 
posted in break rooms.  Incentives valued at less than $10 each were also used to promote 
participation.   
The educational messages were five to ten minute long presentations involving large 
colorful flip charts.  They included information about the amount of UV radiation carriers were 
exposed to and the role of UV radiation in skin cancer development.  They also included a case 
report of a letter carrier with a precancerous growth removed, information about protective 
strategies, and specific details about the hats and sunscreen being made available.  Themes of 
subsequent presentations included: 1) importance of sun safety, even in winter, 2) sun safety for 
eyes, 3) sun safety tips for loved ones, 4) sun safety relevance for carriers of all ethnicities, and 
4) a final recap and encouragement to continue practicing sun protective behaviors.   
In order to assess the efficacy of the program, a delayed intervention group of post offices 
served as a control.  Seventy postal stations in three different regions of Southern California 
ultimately participated, either as an initial program site or a delayed intervention site.  Control 
stations participated in evaluations only for the first two years of the program, until 2 year 
evaluations were completed.  They then received all components of the program over the 
subsequent year.   
Data were collected prior to the start of the program, at 3 months, at 1 year, and at 2 
years.  At the first evaluation, letter carriers were not aware of their station’s study group 
assignment.  Topics measured in the surveys included how often in the past 5 workdays each 
person used a sunscreen with SPF 15 or higher and wide brim hats.  Research assistants directly 
observed a portion of participants prior to each survey to record clothing worn during mail 
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delivery.  Sunscreen-wearing was also validated by correlating the quantity of sunscreen 
removed from the communal pump bottles at each station with the percentage of men and 
women who reported they “always used sunscreen in past 5 workdays”.  Their methods of 
analyzing the data were fairly robust, and analyses were adjusted for the baseline level of each 
corresponding outcome variable.   
Self-reported sunscreen and hat use were consistent with the results of direct observations 
and the measurement of sunscreen removed from the stations.  At 2 years, intervention group 
participants were twice as likely to report always using sunscreen and 2.88 times as likely to 
report using wide brim hats compared to the control stations.  When comparing the intervention 
group at 2 years to baseline, “all the time” sunscreen use increased from 27% to 39% and the use 
of wide brim hats increased from 27% to 40%.   
Overall, this program and its evaluation were well designed and implemented.  Strengths 
of this program include the multi-pronged approach and incorporation of multiple theoretical 
model constructs.  The two year follow-up period is longer than that of other programs and 
allows evaluators to gain a greater sense of how effective the intervention might remain over 
time.  The means of evaluation were also quite robust, incorporating multiple objective ways to 
validate self-reported measures.   
A lack of information regarding the effect of the program on rates of skin cancer is the 
primary weakness of this study.  The other significant weakness of this study is that the 
evaluation was not designed to assess the efficacy of individual components.  As a result, it is 
difficult to anticipate how each individual aspect of the program may have contributed to the 
results.   
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Sunscreen in Transplant Patients 
 Sunscreen in Transplant Patients was a study designed to assess whether wearing 
sunscreen improved prevention of skin cancer among transplant patients
21
.  Because of ethical 
concerns, they could not create a comparison group of transplant patients that did not receive 
recommendations to wear sunscreen.  Instead, they provided education, cues to act, and free 
sunscreen to program participants and education only to the comparison group.   
 In this study, a group of 60 organ transplant recipients received a program including 
written and oral information on sun protection as well as free sunscreen.  They also received 
training on how to properly apply sunscreen.  A matched comparison group received the same 
written and oral information on sun protection but comparison group participants were 
responsible for obtaining their own sunscreen and were not trained how to properly apply 
sunscreen.  Recognizing barriers to sunscreen use such as ease of application and cosmetic 
effects, a preliminary study was used to identify which sunscreen out of five different products 
was deemed most favorable among a small group of transplant patients prior to using the 
sunscreen in this program.  The sunscreen identified was SPF >50, high-UVA absorption, and a 
liposomal formulation.   
 Participants who received free sunscreen completed a diary of all sun protection measures 
used including frequency and amount of sunscreen use.  The reported amount was corroborated 
by counting the number of sunscreen bottles distributed.  After 24 months of follow-up, 
researchers evaluated the incidence of new actinic keratoses, invasive squamous cell carcinomas, 
and basal cell carcinomas on areas of skin that received daily sunscreen application.   
 Over 24 months, the free sunscreen group applied sunscreen an average of 5.6 times per 
week, year round.  At the two-year follow-up, there was a significant difference in development 
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of precancerous and cancerous lesions between the two groups.  In the comparison group, 42 
patients had developed 82 new actinic keratosis lesions.  In the sunscreen group, 102 actinic 
keratoses spontaneously resolved, and no new ones were present.  Eight people in the 
comparison group developed new invasive squamous cell carcinomas compared to none in the 
free sunscreen group.  There was no statistically significant difference between the rate of BCC 
development in the free sunscreen and the control groups.  Two BCCs occurred in the free 
sunscreen group and there were 9 in the control group.   
 A significant strength of this program is a substantial reduction in the most important 
outcomes of interest (development of cancer and pre-cancer) over two years.  Program 
coordinators also addressed some of the barriers to sunscreen use such as ease of use and 
cosmetic effects.  Very little detail was provided regarding what the educational materials 
included, so it is difficult to comment on the content of the educational portion of the 
intervention.   
 One weakness of the program is that though they matched individuals in the free 
sunscreen and comparison groups based on six factors, it is not entirely clear based on the 
information provided in the article whether the two groups would have had similar skin cancer 
outcomes if not for the free sunscreen program.  Other weaknesses of the program are primarily 
due to the potential for confounding effects when considering which portion of the program was 
effective.  Factors that may have affected how likely the program participants were to use 
sunscreen could include that the sunscreen was free, that it was a desirable formulation, and that 
they kept a diary of their sunscreen and sun protective behavior use.  Because the comparison 
group did not get specific advice regarding how to find that same “desirable formulation” 
sunscreen, did not keep a diary (i.e. did not have that regular cue to act), and did not receive 
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training in how to apply sunscreen, it is difficult to determine whether the free sunscreen was the 
primary discerning aspect.  Nonetheless, with components of the program taken together, the 
results were impressive.  
Specialist Dermatology Clinics 
 This study was designed in order to assess whether attending a specialist dermatology 
clinic in London affected levels of compliance with sun protection measures and awareness of 
skin cancer risk in renal organ transplant recipients
27
.  After transplant, participants were given 
advice about sun protective measures by the renal transplant team.  All renal organ transplant 
recipients were then referred to the physician-led specialist dermatology clinic within 6-12 
months of transplantation.  They were recommended to attend the dermatology clinic annually 
after that.   
At the initial dermatology clinic visit, individuals’ risks were determined using a detailed 
history and full clinical examination by a dermatologist.  They were then counseled about their 
risk for skin cancer and advised on sun protective measures and skin self-surveillance.  Sun 
protective measures discussed include detailed information on sun avoidance, use of 
photoprotective clothing, and application of high SPF sunscreen on all exposed body parts daily 
from at least April to October.  Practical advice about types of sunscreen was provided.  Patients 
additionally received supplementary written information.   
To evaluate the effect of attending this clinic, white-skinned patients under long-term 
follow-up in the renal transplant clinic between August 2004 and April 2005 were selected for a 
survey.  Seventy-three percent of those invited to participate responded.  The mean time since 
transplant for all participants was 12.9 years, and 89% had attended the dermatology clinic at 
least once following transplant.  The survey included questions about where patients received 
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information on photoprotection, the nature of the advice, what sun protective measures they 
used, and their understanding of why they were in need of extra photoprotective measures.  
Repeat questionnaires were sent to patients who had not responded within 6 weeks.  If answers 
in the questionnaires were unclear, patients were contacted by telephone to clarify their 
responses.   
The 11% of survey respondents who had never attended the specialty dermatology clinic 
(non-attenders) were somewhat different from those who had attended the clinic at least once 
(attenders).  Of those who had never attended the clinic, none had been previously diagnosed 
with skin cancer.  In contrast, 30% of those who had attended the clinic reported a history of skin 
cancer.  On average, non-attenders also had a shorter time since transplantation (roughly 9 years 
compared to 13 years).  Based on the survey results, those who had attended the clinic at least 
once had more knowledge about their skin cancer risk and reported increased sun protective 
behaviors compared to non-attenders.  Of clinic attenders, 95% reported wearing sunscreen and 
66% reported wearing SPF >25.  In comparison, 68% of non-attenders reported wearing 
sunscreen and only 43% used SPF >25.  Seventy-one percent of attenders were aware that skin 
cancer was the reason for additional skin protective behaviors compared to 42% of non-
attenders.   
 Attendance at the dermatology clinic was correlated with improved knowledge of 
skin cancer risk and use of sun protective behaviors, and strengths of the program include 
providing tailored and periodic education over a long period of time.  However, the evaluation of 
this program has several significant weaknesses.  Primarily, it is impossible to know whether 
attendance at the dermatology clinic resulted in improved knowledge and altered behaviors or 
whether individuals who were more concerned about skin cancer risk were more likely to seek 
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information, use protective behaviors, and attend the clinic.  That there were significant 
differences between the clinic attenders and non-attenders, including much lower rates of 
previous skin cancer among non-attenders, raises the suspicion that the comparison might not be 
valid.  Given these differences between attenders and non-attenders, an alternative explanation 
for their observation may be that the individuals who have a history of skin cancer are both more 
likely to go to a dermatologist and more likely to engage in sun protective behaviors.  An 
additional weakness in the evaluation is that 27% of patients asked to participate did not respond 
to the survey, introducing potential that important information may not have been collected from 
this subset of individuals.   
Educational Outcomes Regarding Skin Cancer in Organ Transplant Recipients: Intensive vs 
Standard Education 
 A program of intensive skin cancer prevention education for organ transplant recipients 
was conducted for roughly 101 patients at the von Liebig Transplant Center at the Mayo Clinic
28
.  
The intensive skin cancer prevention education included initial education after transplant 
followed by repetitive educational mailings.  The initial episode-of-care based education 
included personalized discussion of risk factors, as well as instructions to use sunscreen with a 
sun protection factor of 15 or higher on all exposed skin daily, to wear hats and protective 
clothing, and to avoid peak UV light year-round.  Participants were advised not to tan outdoors 
or indoors.  They were also recommended to perform monthly skin self-examinations and notify 
a health care provider if they noted any changing areas.  The comprehensive Mayo Clinic 
pamphlet Skin Cancer and Organ Transplant Recipients was given to each patient.   
Participants were sent a packet of materials at 2, 6, and 9 months after their initial 
education.  The packets included a cover letter encouraging careful review of the enclosed 
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pamphlets.  At two months, the pamphlets included were the Skin Cancer Foundation pamphlets 
Simple Steps to Sun Safety and Skin Cancer: If You Can Spot It, You Can Stop It.  At 6 months, 
patients received the American Academy of Dermatology pamphlet Skin Cancer—An 
Undeclared Epidemic and leaflet Stop—Look for Danger Signs in Pigmented Lesions of the Skin. 
At 9 months, the Mayo Clinic pamphlet Skin Cancer and Organ Transplant Recipients was sent.   
In order to evaluate this program, a 101 person comparison group comprised of OTRs 
who only received the initial in-person education was formed.  Baseline information obtained 
from both program participants and the comparison group individuals included knowledge, use 
of sun protective measures, intent to change, and perceived barriers to behavior change.   Follow-
up questionnaires assessing knowledge and use of sun protective behaviors were mailed to each 
OTR at 3 and 10 months after the initial education intervention.   
There were some potentially important differences between the program participants and 
the comparison group.  Prior to starting the program, 29% of the intensive education group 
compared to 22% of the comparison group reported already practicing sun protection.  Another 
56% in the intensive group compared to 52% in the standard education group reported intention 
to implement additional sun-protective behaviors in the next 6 months.  Whether these 
differences were statistically significant was not reported.     
Both groups had similar high knowledge scores at baseline, 3-, and 10-months.  Prior to 
the start of the program, they also had similar scores on the assessment of sun-protective 
behaviors.  However, those who received the intensive education materials scored substantially 
higher on the behavioral assessment at 3 and 10 months, a difference which was statistically 
significant.  In particular, the median behavior score (lower is better) for patients in the intensive 
program was statistically significantly lower than in the standard group at both follow-ups.  
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Nonetheless, reported skin self-examination did not follow that trend.  At baseline, 38% of 
intensive program participants reported preforming monthly self-skin exams compared to 41% in 
the comparison group.  At 10 months, 58% of patients in the intensive program reported doing a 
monthly skin self-examination compared to 68% in the comparison group.  Thirty-seven percent 
and 26%, respectively, reported they intended to start.  Among both groups, there was a 
substantial gap between level of knowledge and use of sun-protective behaviors.     
Overall, the intensive education program was associated with higher rates of sun 
protective behaviors at follow-up, but this may have been partly due to differences between the 
two groups.  Prior to starting the program, more renal transplant recipients in the intensive 
education group than in the comparison group reported the intent to add sun protective behaviors 
in the next six months.  This makes it difficult to know whether the improvement in reported use 
of sun protective behaviors on follow-up surveys was due to the program materials or the 
individuals’ intent to change behavior prior to the start of the program.  Other shortcomings of 
this program include depending on self-reported behavior in the evaluation and not being able to 
determine whether changes in sun protective behaviors correlated with lower rates of skin 
cancer.  Because knowledge of skin cancer risk and protective behaviors was high before starting 
the program, it is not possible to assess whether the program would have been effective at 
improving OTR knowledge of skin cancer risk and how to reduce it.   
Strengths of this program include focused efforts on multiple theoretical model concepts 
including perceived threat and barriers to action from the Health Belief Model and readiness to 
change from the Stages of Change model.  The evaluation of this program was relatively strong 
because of using a fairly similar comparison group, assessing both knowledge and behavior, and 
conducting surveys at multiple time points.   
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Project SCAPE 
 Project SCAPE is a program designed to provide mailed, tailored information on skin 
cancer prevention and skin self-examination behaviors
29
.  Primary care clinics in Honolulu, HI, 
and Long Island, NY, recruited adults at moderate to high risk of developing skin cancer for 
participation.  Roughly 360 patients ultimately received the tailored program.   
 In order to provide customized feedback to participants, individuals’ risk levels were 
determined using a previously developed brief skin cancer risk assessment tool
30
.  Additional 
information was collected such as reported sun exposure, sun protection and skin examination 
behaviors, readiness to change, barriers to change, and extent of sunscreen application.  
Participants received three packages in the mail sent at 2-week intervals.  They also received UV 
self-monitoring aids, instructions for skin self-examination, and information about skin cancer 
prevention and detection.   
In order to assess the efficacy of this program, a randomized controlled trial was 
conducted in which control group participants received a single mailing with a sun safety 
booklet, a sheet on sunscreen use, and a bookmark encouraging skin self-examination.  
Participants in the tailored program and the comparison group completed a sun habits survey at 
baseline including information about demographics, knowledge of skin cancer, sun exposure, sun 
protection, and history of performing skin self-examination.  They completed a sun exposure 
diary on two weekdays and two weekend days including information such as using sunscreen, 
wearing a hat, staying in the shade, and covering up.  Telephone interviews were also conducted 
to ask about sun exposure and protection habits in the preceding weekend and inquire about 
reactions to the intervention materials.  Questions about reactions to the interventions were also 
included in the follow-up sun habits survey conducted at some point after the program materials 
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were mailed.  Information about the timing of the follow-up survey and sun diaries was not 
available.  The final number of participants in the trial was 724, and over 80% of those who 
initial completed the baseline survey completed it.  The program group and control group were 
very comparable after randomization.   
Analysis of the survey results showed an increase in sun protective behaviors and 
reduction in sun burns and overall sun exposure in both groups.  However, those who received 
the tailored, mailed program had a greater increase in sun protective behaviors including the use 
of sunscreen, hats, and sunglasses use than those who received the single, non-tailored education 
packet.  Of note, location appeared to play an important role.  In the Honolulu portion of the 
program, people in the control group also significantly increased their sun protective behaviors 
leading to a small difference between the two groups.  In Long Island, the tailored intervention 
group had a much more significant improvement in sun protective behaviors than the control 
group.  Reported rates of skin self-examination increased in both groups, but the effect was more 
pronounced in the tailored education group.  Additionally, individuals at highest risk were more 
likely to report beginning to do skin self-examination than those who were at moderate risk of 
developing skin cancer.  On the program evaluations, the tailored group respondents were more 
likely to report having received the materials, read all of them, and kept them.  They also rated 
their materials much higher on average than those in the control group.   
Strengths of this program include inclusion of tailored materials, consideration of people 
in two geographically distinct locations, inclusion of a large number of people, a thorough 
evaluation, and low cost per person.  Though their evaluation was primarily limited to self-
report, they used multiple methods to evaluate results including surveys, sun diaries, and 
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telephone interviews.  They also went a step farther than most programs and assessed number of 
reported sun burns.   
It would have been helpful if information about timing of evaluation measures was 
included in this program write-up.  Because it is unknown when the surveys, diaries, and 
telephone interviews were conducted, it is not possible to know whether improvements in sun 
protective behaviors were maintained over a long period of time.  Another drawback is the lack 
of assessment of the individual components of the program.  While the evaluation intended to 
determine the effectiveness of the tailored skin cancer risk information, the comparison group 
also differed from the tailored education group in terms of intensity of mailings.  
REACT Skin Self-Examinations 
 This study was design to assess whether providing renal transplant recipients with a skin 
self-examination workbook including an easy to remember mnemonic improved reported rates of 
SSE
31
.  Participants could not be under the care of a dermatologist or have a history of skin 
cancer.  They also had to have undergone transplant either 1 to 1.2 years or 3 to 7 years prior to 
the study.  Three to seven years after transplant is the time window just before SCC typically 
develops and 1 year after transplant was previously identified by the authors as an ideal time for 
SSE education
32
.   
 Out of 80 individuals who met criteria to participate, 38 were randomized to receive the 
program, which consisted of reading the REACT workbook in addition to regular education.  
Another 37 were randomized to the control group in which they received education as usual 
during their physician visit.  Five declined to participate because of insufficient time on the day 
of the visit.       
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 The REACT mnemonic was developed after conducting a systematic review of the 
literature in order to identify clinical features most commonly associated with SCC.  The 
mnemonic was: 
 Red rough spot 
 Evaluate the spot (if possible, invite a partner to check hard to see places) 
 Act if the rough red spot… 
 Changes in 
o Size = diameter increases rapidly in a few weeks 
o Bleeding = easy bleeding 
o Texture = firm, rougher, develops a bump or an open sore 
o Tenderness = slight pricking sensation becomes a sharp stab when something 
brushes over the spot 
 Tell your doctor 
 The REACT workbook consisted of the REACT mnemonic along with 6 other sections 
dedicated to providing knowledge and building skills.  These sections included information 
about anti-transplant rejection medications as a risk factor for SCC, how to identify actinic 
keratoses, the importance of early detection, and the REACT mnemonic.  They also included an 
assessment of personal sun exposure, exercises to recognize actinic keratoses, and actions to take 
if a suspicious area was noted.  The workbook was refined using cognitive interviews (n=25) 
until the last 10 participants did not suggest any changes.   
 In order to evaluate the efficacy of the workbook, all participants completed a baseline 
self-report survey assessing sun exposure, knowledge, cancer concerns, attitude toward SSE, 
self-efficacy for recognizing SCC, SSE behaviors, and likelihood of asking a partner for 
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assistance.  Immediately after reviewing the brochure, intervention group participants completed 
the survey again and also answered questions about their likelihood of performing SSE in the 
next month.  Those in the control group did not retake the survey during their visit.  One month 
after entering the study, participants from both groups responded to a telephone interview.  
At baseline, there was no significant difference in sex, education, skin type, or 
race/ethnicity between the intervention and control groups.  There were also no differences 
between groups with regard to skin cancer knowledge or concern, self-efficacy for detecting 
SCC, or checking their face for skin cancer in the past month.  Control group participants were 
statistically significantly younger compared to intervention group participants (median age 57- 
versus 64-years-old).  They were also statistically significantly more in favor of SSE and more 
likely to have checked their body for signs of skin cancer in the past month.  There were no 
statistically significant differences between the subgroups of patients who underwent transplant 
from 1 to 1.2 years or 3 to 7 years before the study.   
Among intervention group participants, the improved knowledge between baseline and 
the immediate post-workbook survey was statistically significant.  Concern about SCC, reported 
importance of SSE and partner help with SSE, and confidence in recognizing an SCC were also 
statistically significantly increased.  After reviewing the workbook, approximately ¾ of 
individuals reported they would start examining the face and the body in the next month. 
Twenty-two percent of those in the control group checked their skin after the visit 
compared to 89% of those in the intervention group.  No new areas of concern were identified 
among control group participants in the month after the clinic visit, but 35% of intervention 
group participants found areas of concern and made an appointment with a dermatologist. 
Comparing the two subgroups (those transplanted 1 to 1.2 years prior to the intervention and 
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those transplanted 3 to 7 years prior to the intervention), there was no significant difference in 
skin checking or contacting the dermatologist if an area of concern was noticed.  However, the 3-
7 year group was much more likely to find concerning areas compared to the 1-1.2 year group.   
Overall, this program and its evaluation were conducted extremely well.  A major 
strength of the program is the high quality methods used to develop the workbook.  Strengths of 
the evaluation include the use of a similar comparison group, measurement of both knowledge 
and attitudes, and measurement at three time points.  Additionally, a high participation rate 
increases the likelihood that participants were truly representative of the target population.  
 Some statistically significant differences between the groups raise concern that 
randomization was not entirely effective and introduce some possibility of confounding.  Not 
surveying the control group at the end of their clinic visit is another weakness of the study.  
Observed differences between the intervention group pre- and post-surveys may be partly or 
fully due to taking the pre-survey.  Lower rates of post-visit SSE reported by the control group 
compared to the intervention group could be partly because more control group participants had 
already performed SSE recently prior to the visit.  However, very high rates of reported post-visit 
SSE and identification of several suspicious lesions in the intervention group make it less likely 
that the difference in reported SSE between groups was entirely due to baseline differences.  A 
final weakness of the study is reliance on self-reported history of SSE rather than a more 
objective measure.  However, it would be difficult to identify a more objective measure of SSE, 
and self-report of SSE is strengthened by the fact that many concerning lesions were identified 
after administering the program.  
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Analysis 
 Considering these six programs can do a great deal to advise the development of the Skin 
Cancer Prevention Initiative.  Even though there were differences in approach and target 
audience, all programs showed some promise of improving the use of sun protective behaviors or 
skin self-examination behavior
21,25,27-29,31
.  Some of the programs showed gains in skin cancer 
prevention or SSE knowledge
27,28,31
, and one program evaluation showed reduced development 
of skin cancer
21
.  Despite the fact that the target audiences of these interventions are different, the 
process for educating patients and promoting increased use of sun protective behaviors is likely 
to be similar across groups and applicable to OTRs at UNC.   
Key Elements 
 Taken together, the programs had many similar elements.  All programs provided general 
information about skin cancer risk and steps individuals can take to prevent the development of 
or progression of skin cancer
21,25,27-29,31
.  Three of the programs—Specialist Dermatology 
Clinic
27
, Intensive vs Standard Education
28
, and Project SCAPE
29—additionally provided 
assessments of individual risk by a health care provider.  Project SCAPE, the only program 
comparing individualized education versus general education, found greater improvement in sun 
protective behaviors with the individualized education, although that could be confounded by the 
more intensive nature of the individualized program compared to the general education 
program
29
.  Four programs included cues to act on sun protective behaviors either as an 
intentional program component or through requiring a sun diary for the evaluation 
process
21,25,28,29
.  Free sunscreen was a central component of both the Project SUNWISE
25
 and 
the Sunscreen in Transplant Patients
21
 programs.  The results of the Sunscreen in Transplant 
Patients Program suggest that providing free sunscreen, particularly sunscreen selected to be of a 
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desirable formulation, along with instructions to keep a sun diary and directions for proper 
application, has the potential to significantly reduce skin cancers in the OTR population.  Both 
the Intensive vs Standard Education Program
28
 and Project SCAPE
29
 incorporated repeat 
educational mailings as a key portion of their programs.  The REACT skin self-examinations 
program combined comprehensive education geared to improve general knowledge of skin 
cancer risk and SEE with detailed and memorable information about when to suspect SCC
31
.  It 
also included clear information about actions that patients should take to protect themselves from 
skin cancer.   
Implications for the Skin Cancer Prevention Initiative 
In considering how best to design the SCPI, nearly all components of these programs 
could be included.  Assessment of individual risk could be conducted at the UNC Dermatology 
Clinic.  Additional information about skin cancer risk for transplant patients and specific steps to 
reduce an individual’s risk of skin cancer could be provided at the transplant clinics, at 
dermatology visits, and through repeat mailings in between appointments.  The repeat mailings 
would increase the intensity of the educational intervention while also providing cues to act.  
Asking SOTRs to fill out sun diaries might also provide a cue to act and motivation to take steps 
towards sun protection if they could be obtained.  Providing free sunscreen and hats to transplant 
patients could be a useful component to add to the program, but could be logistically more 
challenging.  Either funding or insurance coverage would need to be obtained for both items.  If 
funding could be obtained, sending patients home with a hat would likely be feasible.  However, 
it may be difficult for individuals to carry home sufficient sunscreen at once to last them a year 
once their appointments become less frequent.  If free sunscreen were obtained, another method 
of distribution, such as through the mail, might need to be used.  Finally, teaching patients to 
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perform SSE using clear and memorable methods may hasten detection of skin cancers that arise 
between visits and empower SOTRs to take a more active role in their own care.   
Evaluation 
 With regard to evaluation methods used in the above programs, the five programs with 
moderate to high quality evaluation all used some form of controlled trial
21,25,28,29,31
.  While the 
controlled trials are a higher quality of evaluation than many other types, they are also 
logistically much more challenging to accomplish and may be beyond what is feasible for this 
program.  However, surveys, telephone interviews, and sun diaries may be effective components 
for SCPI evaluation and inclusion of a skin cancer assessment with and without the program 
would be the gold standard if it can be accomplished.   
Conclusion  
 A review of the literature revealed six programs with similar goals as SCPI that all 
showed promising results in terms of increasing sun protective behaviors.  While four of the 
programs focused on OTRs
21,27,28,31
, two others had different target audiences
27,29
.  There were 
some similarities in program components such as skin cancer education, but there were also 
fairly divergent components as well.  Overall, it is extremely difficult to tease out which 
components of the programs may have been the most effective as none used serial evaluation or 
quality improvement techniques to address the usefulness of each component.  However, taken 
as a whole, the programs offered considerable promise for reducing skin cancer risk and the 
majority of the interventions could be incorporated into the SCPI.   
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III. PROGRAM PLAN 
Program Overview 
 Squamous cell carcinoma is the most common cancer to develop after solid organ 
transplant
2




 than in the general 
population.  SOTRs are also at elevated risk of developing BCC
3,6
 and may have an increased 
risk of developing melanoma
6-8
.  The presence of modifiable risk factors related to UV exposure 
creates an opportunity to educate transplant recipients about how to reduce their skin cancer risk.  
Early detection through total body skin examinations performed by health care professionals and 
skin self-examinations could reduce the need for potentially disfiguring surgery as well as the 
risk of metastasis.   
 In response to needs identified at the University of North Carolina, the Skin Cancer 
Prevention Initiative will create a collaborative program between UNC’s transplant clinics and 
Department of Dermatology in effort to improve prevention and early detection of skin cancer 
among UNC’s solid organ transplant recipients.  Key components of the program include (1) 
streamlined referrals to dermatology, (2) risk assessment and individualized risk communication 
(3) providing each transplant clinic with appropriate educational materials and guidelines, (4) 
education about skin cancer risk and sun protective behaviors provided through multiple sources 
both before and after transplant, and (5) free hats and sunscreen provided to transplant recipients.  
The end goal of the program is to reduce the negative effect of skin cancer on quality of life and 
mortality for these individuals.    
Program Context   
In order to develop a comprehensive skin cancer prevention program for UNC’s transplant 
recipients, the context of the program must be carefully considered to identify potential 
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challenges to implementation.  To be successful, the program must be technically feasible as well 
as acceptable to both providers and recipients.  Considering program stakeholders in advance can 
allow involvement of appropriate parties in both program design and evaluation.   
Political Environment 
 The economic recession has significantly affected government funding in the public 
health sector.  Despite continually rising health care expenditures, the Centers for Disease 
Control and Prevention (CDC) budget decreased from $7.31 billion to $6.13 billion between 
2005 and 2012
33
.  State and local public health budgets have also been cut dramatically.  
Between 2008 and 2012, the median per capita state spending on public health decreased from 
$33.71 to $27.40.  As a result, there is both a demand to promote population health in an 
affordable manner and less available funding to sponsor new programs. 
Consistency with Local, State, and National Priorities 
 Within UNC, many different groups promote skin cancer prevention.  The UNC Center 
for Environmental Health and Susceptibility has partnered with multiple local organizations 
including news sources to develop educational materials and increase public awareness about 
skin cancer risk and prevention
34
.  Within each of the transplant clinics, some level of skin 
cancer prevention education is already in place.  Considerable skin cancer research, particularly 
related to melanoma, is conducted at UNC’s Lineberger Comprehensive Cancer Center and the 
Department of Dermatology.   
 North Carolina, the state in which the program will be initiated, has among the highest 
rate of melanoma in the US, at between 23.1 and 32.6 cases per 100,000 people
35
.  In response 
growing concerns about skin cancer, North Carolina passed the Youth Skin Cancer Protection 
Act in May of 2011 in an effort to limit minors’ use of indoor tanning beds36.  Increasing rates of 
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skin cancer across the nation have also prompted recognition by several national agencies.  
Healthy People 2020 set increasing the use of sun protective behaviors as one of the nation’s 
health objectives
37
.  The CDC leads national efforts to reduce skin cancer through education of 
the public about skin cancer risk and prevention
38
.    
 Despite the evidence that skin cancer prevention is consistent with local, state, and 
national priorities, the elevated skin cancer risk and particular susceptibility to SCC among 
transplant recipients is not widely recognized.  As a result, improving awareness of skin cancer 
risk in SOTRs is likely to be an important step in gaining support for this program.   
Acceptability to Stakeholders and Feasibility 
 Key stakeholders in the SCPI program include the transplant recipients as well as the 
staff at all involved clinics.  To ensure acceptability to each of the transplant clinics as well as 
the Department of Dermatology, I conducted interviews with key staff members from each clinic 
to identify needs, preferences, and resource limitations.  For instance, because transplant clinics 
are responsible for monitoring and addressing many different aspects of health for SOTRs, 
taking multiple steps to complete a referral or providing extensive education solely devoted to 
skin cancer prevention in the transplant clinics may not be feasible.  The dermatology clinic is 
also busy, and risk assessment tools and educational materials should be straightforward and 
easy to integrate into the existing clinic structure.  Additional feedback on program efforts will 
be obtained through formal (interviews, surveys, and focus groups) and informal (open lines of 
communication) means.  By reviewing the literature, I identified preferences of SOTRs at other 
sites and used them to guide the initial program plan for the SCPI.  Feedback from UNC’s 
transplant recipients will be a key component of evaluation efforts.   
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 Resource needs and technical requirements of the SCPI program are relatively small 
because the program will be housed within an existing department (the Department of 
Dermatology) at UNC and the bulk of education will be provided at the time of standard medical 
appointments.  A high priority will be to streamline the program within the constraints of 
medical appointments without putting undue stress on health care providers or overwhelming the 
patients.  The program will require a small amount of administrative staffing as well as 
additional staffing during peak evaluation periods.  Minimal additional funding will be required 
to pay for repeat mailings.  The primary funding challenge will be obtaining free hats and 
sunscreen for distribution to transplant recipients.   
Other Potential Barriers 
 Research has shown that SOTRs report considerable mental distress after transplant
39
.  In 
the immediate post-transplant period, SOTRs are faced with recovering from surgery, the 
possibility of acute transplant rejection, multiple medical visits, and increased risk of infection.  
In a series of focus groups and cognitive interviews of recent transplant recipients, Kim et al. 
determined that the optimal time after transplant to provide skin cancer education was 1 year 
after transplant
32
.  Prior to that, SOTRs were too overwhelmed with other aspects of post-
transplant care.  However, because of the risk of acute organ rejection, SOTRs’ level of 
immunosuppression is highest in the first few months after transplant.  As a result, they may be 
at the highest risk of acquiring cancer-promoting sun damage during that period.  To address this 
issue, the SCPI will begin emphasizing skin cancer risk and prevention well before SOTRs 
undergo transplant.   
 Because many of UNC’s SOTRs have traveled from other areas of North Carolina, skin 
cancer prevention efforts at the local level in a single county or town are unlikely to affect the 
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majority of transplant patients.  Unfortunately, the culture of many areas of rural North Carolina 
tends to favor higher levels of outdoor activity without substantial efforts to use sun protection 
(personal observation but no data available).  As a result, encouraging transplant patients to use 
sun protective behaviors may require them to depart significantly from the behaviors they have 
engaged in throughout their lives and the behaviors of those around them.  While a shift of 
attitudes towards sun protective behaviors across North Carolina is beyond the scope of this 
program, educating family and friends who accompany the SOTRs to clinic might promote 
positive attitudes skin cancer prevention among the patients’ closest contacts.   
Financial Resources 
 Possible financial resources for developing and putting in place a program include The 
Skin Cancer Foundation, the Prevent Cancer Foundation, the American Cancer Society, the 
American Skin Foundation, Blue Cross Blue Shield and the Center for Disease Control.  
Insurance companies could potentially serve as a financial resource for patients by covering 
sunscreen and protective clothing such as hats.  This would require collaboration with and buy-in 
from insurance companies but would potentially lower the threshold to act for transplant patients.  
Collaborating with manufacturers may also be a way to obtain free or discounted sunscreens, 
wide brim hats, and sun protective clothing.  
Program Theories 
In order to design the most appropriate program plan and evaluation strategy, I identified 
components of different behavioral change theories as tools for promoting change.  I selected 
both individual and intrapersonal level theories because the primary goal of the program is to 
promote change at the individual level or at the level of their immediate environment.  The 
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selected theories include: the Health Belief Model (HBM), the Precaution Adoption Process 
(PAPM), and Social Cognitive Theory (SCT).   
 The Health Belief Model is based on the theory that individuals’ decisions to adopt health 
behaviors are based on their perceptions of their individual risk of a bad outcome and the 
benefits of trying to avoid that bad outcome
40
.  There are six main constructs to the theory, 
including: perceived susceptibility, perceived severity, perceived benefits, perceived barriers, 
cues to action, and self-efficacy.  Clowers-Webb, et al.
28
 used components of the HBM in 
designing their skin cancer prevention education program for transplant recipients.  Their 
primary methods of promoting behavioral change were to educate patients about their elevated 
risk of skin cancer, the seriousness of skin cancer in immunosuppressed patients in particular, 
and the efficacy of using sun protective measures in reducing that risk.  They used repeated 
mailings at 3-4 month time intervals to provide cues to action and included in these mailings 
pamphlets such as “Simple Steps to Sun Safety and Skin Cancer: If You Can Spot It, You Can 
Stop It” with messages promoting self-efficacy.  They also assessed patients’ perceived barriers 
to taking action in an attempt to inform future program plans.  Using all constructs of the HBM 
is likely to be beneficial in this program plan, just as it was in theirs.  The HBM constructs could 
also guide evaluation efforts.  Surveys of patients in the program assessing where their beliefs 
fall within the HBM constructs could guide where program efforts should be more concentrated. 
 The Precaution Adoption Process Model is another theory focused on individual level 
change that identifies seven stages in the journey from lack of awareness to adoption and/or 
maintenance of a behavior
40
.  It builds on the Stages of Change model by expanding on the 
stages preceding active decision-making and recognizing the differences between individuals 
who have decided not to act and those who are unaware of or unengaged by an issue.  The 
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PAPM stages include: unaware of issue, unengaged by issue, deciding about acting, decided to 
act, acting, and maintenance.  While some constructs between HBM theory and PAPM theory 
are similar, such as awareness of the issue and concern about the issue being required to decide 
whether to act, there are some key differences between the theories.  The PAPM recognizes a 
precontemplation phase which says that even though someone is aware of an issue and 
concerned about it, they have not necessarily decided to act to take steps against it.  It also 
recognizes other important steps in the process such as beginning to act and maintaining that 
action.  Since sun protective behaviors require daily action on the part of the individual, the 
stages of acting and maintaining are crucial steps this program must address in order to 
effectively promote behavior change.  Assessing action and maintenance of action in program 
evaluation will also be important in determining whether the program is meeting its goals.  No 
skin cancer prevention programs for transplant patients have used this theory and so appropriate 
models for promoting sun protective behaviors in the general public are currently being 
identified in the literature.   
 Social Cognitive Theory is based on the premise that human behaviors are not 
determined in a vacuum—they are affected by both personal factors and the environment around 
that person
40
.   The specific constructs of SCT that will be used for the development of this 
program plan include reciprocal determinism and observational learning.  Reciprocal 
determinism, which recognizes the interaction between the person, behavior and environment in 
which the behavior is performed, forms a basis for making adjustment to the individuals 
environment and influencing personal attitudes.  In the case of this program, encouraging family 
members and close friends to adopt sun protective behaviors and support their loved ones to 
adopt them could create an opportunity for environmental adjustments and observational 
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learning.  Additionally, personal attitudes affecting behaviors should be addressed as they can be 
barriers to behavior change.  Such attitudes could include factors such as concerns about 
appearance—whether patients believe tanned skin looks healthy or find it out of place to wear 
long sleeves and hats in summer—and whether outdoor activities are best undertaken at mid-day.  
A systematic review of programs promoting sun protective behaviors among tourists found that 
interventions addressing supportive social norms for sun-protective behaviors and those 
providing appearance-based education about photoaging appeared to be more effective than 
programs solely addressing educational and self-efficacy factors
41
.  This supports the value of 
using SCT to promote behavioral change.   
Goals and Objectives 
Goal:  Reduce the negative impact of skin cancer among UNC transplant recipients.              
Short Term Objectives: 
1.  By month six, 100% of transplant coordinators at participating transplant clinics will have 
received a set of tailored recommendations for how their clinic can help patients reduce their risk 
of skin cancer along with contact information for a project coordinator.  This will include 
published, evidence-based guidelines where possible, as well as a tailored plan designed through 
collaboration between the transplant clinics and dermatology department based on best available 
evidence and feasibility.       
Activities: Identify all relevant guidelines and evidence-based practices for skin cancer 
prevention in transplant patients. 
 Activities: Interview a transplant coordinator from each clinic in order to assess the clinic 
 structure and what program approaches may be most feasible for implementation.  
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 Provide contact information for program coordinators at this visit and encourage 
 continued communication of requests, questions, and concerns.  
 Activities: Consult with dermatologists to determine additional steps where professional 
 guidelines and evidence-based practices are not available.   
 Activities: Collaborate to develop a tailored set of recommendations for each clinic based 
 on guidelines and evidence, dermatologist recommendation, clinic structure, and 
 preferences of clinic staff.   
 Activities: Distribute recommendations to all transplant coordinators within each 
 participating clinic. Follow-up to ensure all transplant coordinators at participating clinics 
 received the recommendations and have no questions.  
2. By month 18, 80% of patients added to the wait list at participating transplant clinics will be 
seen at the UNC dermatology clinic within 6 months of being added to the wait list.     
Activities: Establish a streamlined dermatology referral process requiring minimal work 
from transplant clinic staff so that appointments are automatically made for patients on 
days they have other UNC appointments, if possible.   
Activities: Add dermatology referral to the checklist used at the time of adding patients 
to the waitlist. 
3. By month 18, 100% of patients who have been seen by dermatology will have their skin 
cancer risk level documented in their medical record. 
 Activities: Identify evidence-based risk assessment tools that are relevant to waitlist 
 patients and feasible to implement at a busy dermatology practice.   
 Activities: Identify evidence-based risk assessment tools that are relevant for post-  
 transplant patients and feasible to implement at a busy dermatology practice.   
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 Activities: Streamline the identified risk assessment information into a single, easy-to-
 use risk assessment tool if waitlist and post-transplant risk factors are sufficiently 
 similar.  If not, streamline the information into two distinct easy-to-use risk assessment 
 tools.   
Activities: Ensure an appropriate system of flagging waitlist and post-transplant patients 
is in place at the dermatology clinic so that the appropriate risk assessment tool and 
educational materials are included with patient charts at the time of clinic check in.  
Activities: Add a transplant patient template to the electronic medical record system so 
that physicians in dermatology are reminded to record patients’ risk levels in the system.     
4. By year two, patients at participating transplant clinics will attend 75% of recommended 
dermatology visits.   
Activities: Establish a streamlined dermatology referral process requiring minimal work 
from transplant clinic staff so that appointments are automatically made for patients on 
days they have other UNC appointments, if possible.   
Activities: Provide patient education about skin cancer risk at transplant clinics so that 
patients consider attending the dermatology clinic to be important.   
5. By year two, 80% of light-skinned patients at participating clinics who are more than 12 
months out from their transplant will be able to report that they are at higher risk for skin cancer 
than the general public, identify skin cancer as the reason extra sun protective measures are 
encouraged, and name at least three steps they can take to reduce their risk of developing 
advanced skin cancer. 
Activities: Locate appropriate reading level educational materials for distribution to 
patients.  
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Activities: Establish a timeline and plan for distributing materials (e.g. at transplant clinic 
visits, dermatology clinic visits, and through periodic mailings).  
Activities: Collaborate with transplant clinic staff to make educational materials 
available in patient rooms and the waiting area.   
Activities: Educate transplant and dermatology clinic staff on appropriate skin cancer 
prevention education to provide to patients at each visit, both before and after transplant. 
Activities: Refer patients to dermatology 6 months after their transplant and then at 
intervals appropriate for their skin cancer risk so that patients are engaged in discussions 
about their skin cancer risk in a specialty clinic setting as well as receive appropriate skin 
screenings.  
Activities: Add referral to dermatology at to the checklist used at the first transplant 
clinic visit after transplant. 
Activities: Collaborate with transplant clinic staff to periodically include skin cancer 
prevention topics in educational presentations provided to transplant recipients and clinic 
staff.     
6. By year two, 60% of light-skinned patients at participating clinics who are more than 12 
months out from their transplant will report that they conduct total body skin self-examinations 
at least 6 times per year.   
Activities: Identify or develop at least one written SSE resource that includes information 
about the importance of regular SSE, comprehensive and memorable information about 
how to identify cancerous or precancerous areas (particularly SCC), and clear directions 
for how to proceed if a concerning area is found.  
Activities: Determine when and where to provide written information about SSE. 
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Activities: Encourage transplant and dermatology clinic staff to promote regular SSE for 
transplant patients at each visit.   
Long Term Objectives 
1. By year 3, all transplant clinics at UNC will use this program or a modified version of this 
program that includes regular and adequate education as well as an adequately regular and 
streamlined process for referring to dermatology.   
2. By year 3, communication will be established between UNC Dermatology and dermatology 
clinics across the state of North Carolina so that transplant patients can be followed by a 
dermatologist in their hometown if they prefer but tenets of the SCPI are still promoted at their 
clinic and UNC Dermatology remains a safety net. 
 Activities: Identify as many dermatology clinics across the state of North Carolina as 
 possible.   
 Activities: Send the identified clinics a letter about the SCPI and ask them to respond 
 if they would like to be involved.  
 Activities: Establish a list of dermatology clinics interested in caring for transplant 
 patients.   
 Activities: If a transplant recipient has an existing dermatologist not on that list, send the
 clinic a letter detailing the SCPI, stating the recommended education and risk 
 assessment, and asking for collaboration.  
 Activities: Make it clear to all collaborating clinics that UNC Dermatology has a high-
 risk skin cancer clinic available if their SOTRs begin to develop multiple cancers.  
3. By year 5, obtain free or discounted sunscreen and hats for at least 75% of light-skinned 
transplant patients at participating clinics.  
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Activities: Meet with Blue Cross Blue Shield (the primary payer for UNC transplant 
patients aside from Medicare) to discuss feasibility of covering sunscreen and a one-time 
hat purchase for transplant patients.  
Activities: Contact hat manufacturers about providing free or discount hats on a one time 
basis for all transplant patients.  
Activities: Contact sunscreen manufacturers about providing free or discount sunscreen 
to transplant patients.  
Activities: Contact businesses (sunscreen and hat manufacturers, UNC stores, etc) about 
donating a percent of proceeds from a certain item towards providing sunscreen and hats 
for transplant patients. 
Activities: Identify and apply for grants that could provide funding to purchase hats and 
sunscreen for transplant patients.  
4. By year 5, 40% of Caucasian transplant recipients will report always wearing a wide brim hat 
for outdoor activities and 60% of Caucasian transplant recipients will report applying adequately 
high SPF sunscreen at least 5 days per week year round prior to going outside.   
 Activities: Incorporate patient family and friends in educational efforts when possible.  
5.  By year 5, a 20% reduction in invasive skin cancers will be observed among UNC transplant 
patients.  
While the overall goal and primary objectives are expected to remain stable through the 
development of the program plan and evaluation, specific targets may need to be adjusted after 
identifying baseline data for this population.  Baseline data for a similar population is not 
available for comparison due to variation in skin cancer prevention programs at different 
institutions, and relatively little evidence exists to suggest what may be reasonable targets.  
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Ideally, this program seeks to set lofty but obtainable targets and determine success based on 
meeting 80% of target measures.  These targets may also be adjusted prior to full-scale 
implementation of the program based on feedback from stakeholders, including transplant 
recipients, transplant clinic personnel, and dermatology clinic personnel.   
Program Implementation 
Activities 
The first step of the SCPI will be establishing clear lines of communication between the 
UNC transplant clinics and Department of Dermatology.  We will then develop and distribute 
tailored recommendations for improving skin cancer prevention education to each transplant 
clinic based on the clinic’s structure and patient population as well as the best evidence available 
for promoting sun protective behaviors in transplant recipients.  Our other activities will be 
related to five key program components, including: improving dermatology clinic attendance, 
conducting risk assessment, improving education about skin cancer risk and prevention 
measures, and providing free sunscreen and hats.  A timeline for how these activities will be 
implemented is included in Table 1. 
Improve Dermatology Clinic Attendance 
 At the heart of efforts to improve rates of dermatology clinic attendance is streamlining 
the referral system.  This will be achieved by having transplant clinics send appointment requests 
to a single point-person within dermatology who is familiar with scheduling these patients.  
Patients will no longer have to schedule their own appointment, and their appointment at both 
clinics will be on the same day when possible, thus reducing barriers to action for SOTRs.  Other 
steps to improve dermatology clinic attendance include adding reminders to transplant clinic 
checklists at the appropriate times, focusing on patient education so they understand the need for  
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Table 1: SCPI Implementation Timeline 
Activity Staff Involved Timeline 




Administrator and Coordinator Month 1 
Conduct baseline evaluation Researcher, Administrator, 
and Coordinator 
Month 2-6 
Identify relevant guidelines 
and evidence-based 
practices, educational 
materials and risk 
assessment tools 
Coordinator Months 2 and 3 
Develop dermatology referral 
system 
Administrator and Coordinator Month 3 
Develop tailored sets of 
recommendations for 
each clinic 
Coordinator Month 4 




Administrator and Coordinator Month 5 
Conduct orientation/training 
sessions with all 
transplant coordinators 
Administrator and Coordinator Month 6 
Streamline risk assessment 
tools for use at the 
dermatology clinic 
Administrator and Coordinator Month 7 
Add dermatology referral to 
waitlist checklist 
Administrator Month 7 
Streamline system for 
managing patient visits 
in dermatology 
Administrator and Coordinator Month 7 
Identify additional potential 
sources of funding and 
requirements 
Administrator Month 7-8 
Meet with BCBS Coordinator Month 7-8 
Contact other potential 
business collaborators 
(e.g. sunscreen and hat 
manufacturers) 
Coordinator Month 7-8 
Complete grant applications Coordinator and Administrator Months 9-12 
Conduct initial evaluations Coordinator and Administrator Months 9-12 
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the visits, and establishing a network of dermatologists across the state to provide care to SOTRs 
who are committed to being followed by a dermatologist in their hometown.  After the first visit 
while on the wait list and the first visit after transplant, dermatology clinic staff will be 
responsible for scheduling dermatology visits at appropriate intervals for each patient.  
Risk Assessment 
 Conducting risk assessment at dermatology visits will allow health care providers to 
provide patients with individualized information about their skin cancer risk and help ensure that 
patients receive total body skin examinations at appropriate intervals based on that risk.  We will 
review existing literature about risk factors and risk assessment tools.  Based on that, we will 
identify or create one to two risk assessment tools that can be used for SOTRs on the waitlist and 
after transplant.  Flagging transplant recipients at the time of dermatology clinic check-in will 
allow staff to put the appropriate risk assessment tool and educational materials with each 
SOTR’s chart to ensure their level of risk is determined.  Transplant recipient templates (waitlist 
and post-transplant) in the electronic medical record system will remind physicians to record the 
individual’s risk in their charts for later reference.   
Improve Education About Skin Cancer Risk and Promote Prevention Measures 
 We will work to improve awareness of and engagement by skin cancer prevention by 
educating SOTRs at multiple time points, including before transplant and one year after 
transplant to maximize their ability to absorb the information.  The education will include 
information about skin cancer risk, sun protective measures, and skin self-examination.  It will 
be provided through repeat mailings and by multiple different individuals, including a specialist 
dermatology clinic where personalized risk information can be discussed.  Drawing from the best 
available literature and guidelines on SOTR skin cancer prevention education will ensure that the 
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education is the highest quality available.  Providing written materials and clearly laying out a 
plan of education for each clinic will ensure health care providers are aware of the latest 
recommendations and make it easier for them to engage SOTRs in education.  Transplant 
recipients will also receive lectures on skin cancer prevention periodically within existing lecture 
series’, and skin cancer prevention educational materials will be placed in the transplant clinic 
waiting room and clinic rooms.  Recognizing that environment and attitudes affect decision-
making, we will further promote behavior change by providing skin cancer prevention education 
to family members and close friends who accompany SOTRs to clinic and by including 
appearance-based benefits of sun protection in some of the educational materials.   
Free Sunscreens and Hats 
Obtaining free sunscreens and hats is likely to be the most difficult portion of the 
program.  However, evidence that providing free sunscreen may substantially reduce the 
development of skin cancers in SOTRs also makes it likely to be worthwhile.  To achieve this 
objective, we will meet with Blue Cross Blue Shield about the risk of skin cancer in SOTRs, the 
evidence for using sunscreen, and the potential for sunscreen coverage in this population to 
generate cost-savings.  We will contact several manufacturers of sunscreens, hats, and other sun-
protective clothing in attempt to solicit donations or discounts.  We will also apply for grants that 
could fund the purchase of hats and sunscreen and contact businesses about donating a percent of 
proceeds from certain items in order to cover the cost of sunscreen and hats.   
Resource Needs 
The Skin Cancer Prevention Initiative is expected to be a fairly low-budget (Appendix 
A), cost-effective means of promoting skin cancer prevention among transplant patients, largely 
because it functions within existing systems of care.  To meet funding needs, we will apply for 
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funding from several organizations including: Blue Cross Blue Shield Foundation of NC, Skin 
Cancer Foundation, Prevent Cancer Foundation, American Cancer Society, and American Skin 
Foundation.   
Personnel: Total $113,750 over 5 years 
An existing dermatology clinic staff member will receive $10,000 per year to oversee 
program implementation for all years of the program.  A single part-time coordinator (20 hours 
per week) with a background in public health will be required for the first year to coordinate with 
clinics, provide training, ensure goals are being met, and oversee evaluations.  Additionally, a 
part-time researcher (20 hours per week) will be required for the first six months to collect 
relevant background data on the patient population and document important baseline information 
to contribute to future evaluation efforts.  In years three and five, a researcher will need to be 
hired part-time (20 hours per week) for six months of the year to aid in conducting program 
evaluations.   
Supplies: Total $25,900 over 5 years 
 Brochures and educational materials will be obtained or printed for post-transplant 
patients at an expected cost of $3 per person per year.  Brochures and educational materials for 
pre-transplant patients will be provided at visits sent through the mail at a cost of $8 every five 
years ($3 for cost of printing and $5 for mailing).  An additional $500 per year for miscellaneous 
printing and office supplies was included in the budget.   
Total Cost over 5 years: $164,650 
 In addition to personnel and supply costs, $5000 per year was included in a discretionary 
fund to cover unexpected expenses or unanticipated opportunities.   
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Logic Model (Table 2) 
Assumptions 
 Solid organ transplant recipients (SOTRs) are at markedly elevated risk for developing 
skin cancer, particularly squamous cell carcinoma (SCC).
2
  
 Sun exposure is a significant modifiable risk factor for the development of non-
melanoma skin cancer among SOTRs
17,19
.   
 Higher rates of aggressive skin cancer have a negative effect on quality of life of SOTRs, 
and treatment of these cancers incurs substantial cost and use of resources.  
 Various surveys have identified deficits in SOTR’s knowledge of skin cancer risk and 
prevention measures
22,23
.  We assume the use of sun protective behaviors has not yet been 
maximized among UNC transplant patients.   
 Interventions such as regular education29, providing free sunscreen21,25 and hats25, and 
referring to high-risk dermatology clinics
27
 has the potential  to reduce both development 
of skin cancer and poor outcomes as a result of skin cancer in the SOTR population.  
 Early detection of skin cancers can reduce the need for invasive treatment and reduce the 
risk of metastasis.  
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Table 2: SCPI Logic Model 
 
INPUTS ACTIVITIES OUTPUTS 
OUTCOMES (1-3 




 SCPI staff 
 UNC SOTRs 
 Meet with UNC Transplant 
Clinics and Dermatology 
Department to gain support 
and learn about existing 
clinic structures 
 Identify relevant guidelines 
and evidence-based 
practices, educational 
materials and risk 
assessment tools 
 Distribute tailored skin 
cancer prevention 
recommendations and 
educational resources to all 
transplant coordinators 
 Add dermatology referral 
to the checklist used when 
adding patients to 
transplant waitlists 
 Develop risk assessment 
tool for dermatology 
department 
 Put in place system for 
managing transplant 
recipients and waitlist 









 Improved transplant 
coordinator level of 
knowledge of skin 
cancer risks 
 Improved SOTR 
knowledge of skin 
cancer risks 
 SOTRs will receive 
skin cancer education 
at transplant and 
dermatology clinic 
visits and by mail  
 Transplant clinic staff 
will have triggers for  
referring to 
dermatology 
 Dermatology clinic 
staff will have 
reminders and tools to 
risk stratify all patients 
 Education about 
regular skin self-
examination will be 
provided 
 
Short Term (1-3 Years): 
 All transplant coordinators at 
participating clinics will have a 
tailored set of recommendations 
for how their clinic can help 
patients reduce their risk of skin 
cancer  
 80% of patients added to the wait 
list at participating clinics will be 
seen in the dermatology clinic 
within 6 months of being added 
to the list 
 100% of patients seen in 
dermatology will be risk 
stratified, and their risk level will 
be recorded in their medical 
record 
 Patients at participating 
transplant clinics will attend 75% 
of recommended dermatology 
visits 
 80% of light-skinned patients at 
participating clinics will be 
knowledgeable of their elevated 
risk of skin cancer and need for 
additional sun protective 
measures 
 60% of light-skinned patients 
will report conducting SSE at 
least 6 times per year 
 Reduced 
development 











































clinics in need 





 UNC Transplant 
Clinics 





clinics across the 
state 




 Hat companies 
 Grant agencies 
 
 Contact dermatology 
clinics across the state with 
information about the SCPI 
and a request for 
collaboration  
 Meet with BCBS to discuss 
feasibility of covering 
sunscreen and a one-time 
hat purchase for transplant 
patients 
 Contact hat and sunscreen  
manufacturers about 
providing free or 
discounted hats or 
sunscreen 
 Involve SOTRs’ family and 
friends in educational 
efforts 
 Contact businesses about 
donating a percent of 
proceeds from certain items 
towards sunscreen and hats 
for transplant patients  
 Contact grant agencies to 
seek funding that would 
cover sunscreen and hats 
 Dermatology clinics 
across the state that are 
interested in caring for 
transplant recipients 
are identified and 
made aware of the 
SCPI 
 BCBS and 
manufacturers are 
aware of substantially 
elevated risk of skin 
cancer among 
transplant recipients 
 BCBS is aware of 
potential cost savings 
that might be achieved 
from providing 
sunscreens and hats for 
transplant patients 
 A sustainable source of 
hats and sunscreen or 
funding for hats and 
sunscreen will be 
obtained 
 SOTRs’ close family 
and friends will be 
aware of their skin 
cancer risk 
Long Term (3-5 Years): 
 Establish a network of 
dermatology clinics across the 
state who are willing to care for 
SOTRs who prefer to be seen at 
their hometown 
 Obtain free or discounted 
sunscreens and hats for at least 
75% of light-skinned patients at 
participating clinics 
 Have the program or a variation 
of the program implemented at 
all of UNC’s transplant clinics 
 40% of light-skinned transplant 
recipients report always wearing 
a wide brim hat for outdoor 
activities and 60% report 
applying adequate quantities of 
sunscreen at least 5 days per 
week year round prior to going 
outside 
 20% reduction in invasive skin 










 Brochures from 




and other reliable 
sources 
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IV. EVALUATION PLAN 
Evaluation Rationale 
 Evaluation of the Skin Cancer Prevention Initiative is important for several reasons.  It 
will help us determine how effectively different activities are being implemented, monitor 
progress towards program goals, and ensure acceptability of the program for providers and 
recipients.  It will help program staff identify areas for continued quality improvement and help 
justify further funding and support.  Through publishing, evaluation also allows an opportunity 
to share with others which aspects of the program are successful, which are not, and how future 
program designs might be improved.   
Evaluator’s Role 
 For this program, I recommend using an internal evaluator with an external consultant.  
An internal evaluator has several advantages.  Among these are increased familiarity with the 
inner workings of the program and access to organizational resources
42
.  Because this program is 
based on collaboration between different medical departments, each with their own systems and 
protocols, an effective evaluator will need to have substantial insight into the program and 
collaborating departments.  Additionally, the evaluator should be familiar with transplant 
recipients in order to address unique challenges of providing them with care.  An internal 
evaluator is also more likely to establish good rapport with program staff.  This may help them 
obtain informal feedback about the program to guide the evaluation process and may promote 
increased stakeholder involvement in the evaluation process.  However, it may also make it more 
challenging for them to discuss areas in need of improvement with program staff.  Adding an 
external consultant provides a third-party viewpoint about program activities and needed 
evaluation activities.  This can be important both to provide fresh perspective and to help ensure 
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that an internal evaluator is not overly swayed by his or her relationship with other program staff.  
Additionally, it may be easier to identify an external consultant with a high level of technical 
expertise in program evaluation than it would be to identify an internal evaluator with that 
expertise.  As a team, the evaluators should be observant, flexible, good at communicating and 
problem solving, and skilled in evaluation and research methods.  They must also keep in mind 
that the most important goal of the evaluation is to obtain useful information.     
Stakeholders 
 All key stakeholders—including transplant clinic staff, dermatology clinic staff, and 
transplant recipients—should be involved in the evaluation process.  If the program is not 
functioning well for any of these key groups, it will fail to be optimally successful and may fail 
completely.  Both transplant clinic staff and dermatology clinic staff are likely to be concerned 
with fitting the program seamlessly into their existing clinic structure.  Because of busy clinic 
schedules, a program that requires too many extra steps or too much time is not likely to be 
maintained for long.  For transplant clinic staff, this is likely to be even more important since 
they must address a multitude of medical issues at each clinic visit.  For both clinics, the 
program’s standard procedures will need to be easy to disseminate to the many different 
personnel required to make it run smoothly.  Because transplant recipients are likely to have 
other priorities besides skin cancer prevention, they may be most concerned with how material is 
presented and whether its presentation dramatically increases the stresses associated with 
transplantation.  A variety of methods can be used to involve all of these stakeholders in the 
evaluation process, starting from the initial design of the evaluation plan.  Feedback from 
transplant and dermatology clinic staff could be obtained through informal discussions, formal 
interviews, focus groups, and surveys.  Maintaining open lines of communication between 
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program staff and other clinic staff will be a key means of identifying areas for potential 
improvement.  Information from transplant recipients could be obtained primarily through focus 
groups and surveys.   
Potential Challenges 
 In the process of conducting this evaluation, we will undoubtedly come across 
challenges.  Because the program involves so many different clinics, there are certain to be many 
different perspectives on what is important that will need to be addressed.  Additionally, what 
works well for one transplant clinic may work very poorly for others, so determining how well 
the program works for each of the different transplant clinics will be important.  The busy nature 
of the dermatology and transplant clinics may also make it difficult to conduct evaluations during 
or between patient visits.   
 The transplant recipient population also poses challenges.  Many of the individuals do not 
use internet and may have varying levels of literacy.  As a result, evaluation methods must be 
structured in such a way that many transplant recipients are able to give high quality feedback 
about the program.  Because knowledge about skin cancer is not directly correlated to sun 
protective behaviors
28
, the two will need to be measured separately in the evaluation.  Finally, we 
must take into account that the outcomes of primary interest (reducing the burden of skin cancer 
in this population) are likely to be removed from the intervention by a few years.  In the interim, 
we will have to evaluate intermediate outcomes.  When skin cancer related outcomes begin to 
appear in a few years, we will need to use appropriate methods to reduce the likelihood of 
confounding.   
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Evaluation Design 
 The goal of comprehensively evaluating the Skin Cancer Prevention Initiative is to 
determine how effectively the program is meeting its goals and objectives.  The evaluation 
should include measures of both implementation and outcomes, and it must also be feasible to 
conduct.  To evaluate the program implementation and outcomes, we will use components of 
both quasi-experimental and observational designs.  
One Group Pre- and Post-Test Design 
 The first quasi-experimental design we will use is a one group pre- and post-test design.  
The reason for conducting a pre-test assessment is to generate baseline comparison data that can 
be used to compare post-test performance.  The data will be connected in such a way that 
individual’s data can be analyzed at both time points and the amount of improvement between 
the pre- and post-test measures can be determined.  This should indicate how effective our 
program has been at reaching its goals.  The data can also be analyzed at the group level.  
Advantages of this type of evaluation strategy include low cost and feasibility.  Some 
disadvantages include a risk of maturation bias and history threats.  Maturation bias, or a change 
in outcomes due to participant maturation independent of the program, is a particular concern 
because as transplant recipients get farther out from their transplant and their skin cancer risk 
increases, they may naturally become more concerned about skin cancer.  History threats could 
be present if another event occurring between the baseline assessment and the post-test 
assessment affects the results.   
 In attempt to reduce the potential for confounding due to maturation, we will do a group 
level comparison between individuals at various post-transplant years at baseline and individuals 
at that same point post-transplant during follow-up visits.  For instance, we will compare 
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baseline responses from a group of participants who is one year out from their transplant to 
follow-up responses from the group that is one year out from their transplant.  This group level 
method will also be employed to assess skin cancer development.  Because the risk of skin 
cancer increases yearly after transplant, a comparison of skin cancer development at baseline and 
follow-up for a group of individuals is expected to demonstrate higher rates of skin cancer at the 
post-test assessment.  To address this, we will compare baseline skin cancer data for individuals 
1-, 3-, 5-, and 10-years from transplant with follow-up data for individuals who are 1-, 3-, 5-, and 
10-years from transplant at the time of follow-up. 
 Clinic processes can also be conducted within a pre-test and post-test framework, 
allowing program evaluators to determine whether clinic processes have changed over time in 
conjunction with the SCP Initiative.  These assessments could determine aspects of 
implementation such as how frequently patients are referred to dermatology, how frequently skin 
cancer prevention is a topic at patient seminars, and how often transplant recipients are risk 
stratified at dermatology visits.  
Ecological Design  
 To provide a second measure of how our program may be affecting skin cancer rates, we 
will use another quasi-experimental design—an ecological study.  Using this design, changes in 
annual skin cancer rates over time among transplant recipients at UNC will be compared with 
skin cancer rates among transplant recipients at nearby transplant centers.  If the annual rate of 
skin cancer among transplant recipients at UNC is diminishing faster at UNC than at other 
institutions or growing more slowly at UNC than at other institutions, this supports a conclusion 
that the program is effective at reducing skin cancer development.  However, this must be 
interpreted cautiously due to limitations of this design. 
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Observational Design Components 
 Both of the above designs will include observational components, including focus 
groups, surveys, open-ended interviews and document review.  In addition, an observational 
design will be used to assess important factors such as program acceptability, success of program 
implementation, and challenges faced during implementation.  An observational design will also 
be used to identify suggestions for improvement from key stakeholders.   
Evaluation Techniques 
 To assess the SCP Initiative, we will collect both qualitative and quantitative data.  
Qualitative methods include open-ended interviews, surveys, and document review.  Quantitative 
analytical methods include assessment of skin cancer rates based on medical chart review and 
rates of process measures such as dermatology referral and risk assessment as determined by 
program records. 
 Evaluators will conduct open-ended interviews and focus groups with transplant 
recipients, transplant clinic staff, and dermatology clinic staff.  These interviews and focus 
groups will assess acceptability of the program to key stakeholders, experiences with the 
program, barriers to fully implementing the program, and areas for program improvement.  
Evaluators will also conduct surveys of each of these groups to determine how effective the 
program has been at improving clinic processes and knowledge of participants and clinic staff.   
 Review of program documents will be a key means of determining efficiency of program 
processes.  This will allow evaluators to determine measures such as how frequently 
dermatology referrals and risk assessment are completed and how frequently transplant 
recipients attend clinic visits.  Finally, medical record review will be used to determine skin 
cancer incidence among transplant recipients both before and after program implementation.   
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Evaluation Planning Tables 
Short-Term Objective 1:  (Process Objective) 
By month six, 100% of transplant coordinators at participating transplant clinics will have 
received a set of tailored recommendations for how their clinic can help patients reduce their risk 
of skin cancer along with contact information for a project coordinator.  This will include 
published, evidence-based guidelines where possible, as well as a tailored plan designed through 
collaboration between the transplant clinics and dermatology department based on best available 
evidence and feasibility.      
Evaluation Questions Participant Evaluation Method 
Did each transplant 
coordinator receive a 
tailored set of 
recommendations 
within six months of 
the program start? 
Program Coordinator Review of documents: emails, 
meeting notes 
Were relevant guidelines and 
evidence-based 
practices for skin 
cancer prevention in 
transplant recipients 
identified? 
Program Coordinator and 
Dermatology Faculty 
Document review: evidence 




review articles in the 
field  





Dermatology Faculty Open-ended interviews 
Document review: tailored 
recommendations 
What program approaches 
may be most feasible 
for implantation in 
each participating 
clinic? 





Did any transplant clinics 
decline to participate?  
Why? 
Transplant Coordinators Open-ended interviews 
Was the final set of 
recommendations for 
Transplant Coordinators Open-ended interviews 
Document review: tailored 
 Moye 52 
 
each clinic acceptable 
for that clinic? If not, 
how could it be 
improved? 
recommendations 
Was open communication 
throughout the process 






Short Term Objective 2: (Process Objective) 
By month 18, 80% of patients added to the wait list at participating transplant clinics will be seen 
at the UNC dermatology clinic within 6 months of being added to the wait list.    
Evaluation Questions Participant Evaluation Method 
By month 18, what percentage 
of patients added to the 
wait list at 
participating transplant 
clinics seen at UNC 
dermatology clinic 
within 6 months of 





Document review: transplant 
clinic waitlists, chart 
review, dermatology 
clinic calendars 







Open-ended interviews, Focus 
groups 
Was dermatology referral 
included in key 





Document review: key 
checklists 
What challenges have 
dermatology clinic 
staff experienced with 
seeing these transplant 
recipients? 
Dermatology Clinic Staff Open-ended interviews, focus 
groups 
 
Short-Term Objective 3: (Process Objective) 
By month 18, 100% of patients who have been seen by dermatology will have their skin cancer 
risk level documented in their medical record. 
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Evaluation Questions Participant Evaluation Method 
By month 18, what percentage 
of transplant recipients 
seen by dermatology 
had their skin cancer 
risk level documented 
in their medical 
record?  
Dermatology Clinic Staff Document review: list of 
transplant recipients, 
medical chart review 
Is the dermatology clinic’s 
system for flagging 
waitlist and post-
transplant recipients at 
check-in effective? 
Dermatology Clinic Staff 
(check-in staff) 
Open-ended interviews, Focus 
groups 
Is the risk assessment tool 
easy to use?  Is there a 
way to make it more 
straightforward? 
Dermatology Clinic Staff 
(physicians and 
residents) 
Open-ended interviews, Focus 
groups 
Is an appropriate system in 
place to remind 
physicians and 
residents to record the 
risk level in medical 
records? 
Dermatology Clinic Staff 
(physicians and residents) 
Open-ended interviews, Focus 
groups 
Are physicians using the 
transplant patient 
template in the 
electronic medical 
record system?  Could 
it be improved? 
Dermatology Clinic Staff 
(physicians and residents) 
Open-ended interviews, Focus 
groups 
 
Short-Term Objective 4: (Process Objective) 
By year two, patients at participating transplant clinics will attend 75% of recommended 
dermatology visits.   
Evaluation Questions Participant Evaluation Method 
By year 2, what percentage of 
recommended 
dermatology visits are 
attended by patients at 
participating transplant 
clinics? 
Dermatology Clinic Staff  Document review: transplant 
clinic patient lists, 
dermatology clinic 
transplant recipient 
list, medical chart 
review 
What barriers are in place to 
prevent patients from 
Transplant Recipients, 
Transplant 
Open-ended interviews, Focus 
groups, Surveys 




dermatology visits?  
Can these be addressed 
by a change in the 
program? 
Coordinators 
Do transplant recipients at 
participating clinics 
feel that attending 
dermatology clinic 
visits is important? 
Transplant Recipients Surveys 
 
Short-Term Objective 5: (Outcome Objective) 
By year two, 80% of light-skinned patients at participating clinics who are more than 12 months 
out from their transplant will be able to report that they are at higher risk for skin cancer than the 
general public, identify skin cancer as the reason extra sun protective measures are encouraged, 
and name at least three steps they can take to reduce their risk of developing advanced skin 
cancer. 
Evaluation Questions Participant Evaluation Method 
By year 2, what percentage of 
light-skinned patients 
at participating clinics 
who are more than 12 
months out from their 
transplant can report 
that they are at higher 
risk for skin cancer 
than the general public, 
identify skin cancer as 
the reason extra sun 
protective measures 
are encouraged, and 
name at least three 
steps they can take to 




Transplant Recipients Survey 
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Are educational materials 
accessible (available, 
appropriate reading 
level) to patients? 
Transplant Recipients Focus groups, Baseline and 
Follow-up Surveys 
Are transplant clinic staff 
members well 
educated about skin 
cancer risk and 
prevention for 
transplant recipients? 
Transplant Clinic Staff Surveys, Open-ended 
interviews 
How can educational efforts 
be improved? 
Transplant Clinic Staff, 
Transplant Recipients 
Open-ended interviews, Focus 
Groups, Surveys 
Are skin cancer prevention 
topics being regularly 
included in seminars 
and mailings provided 
to transplant recipients 
from the transplant 
clinics?  





Short-Term Objective 6: (Outcome Objective) 
By year two, 60% of light-skinned patients at participating clinics who are more than 12 months 
out from their transplant will report that they conduct total body skin self-examinations at least 6 
times per year.   
Evaluation Questions Participant Evaluation Method 
By year 2, what percentage of 
light-skinned patients 
at participating clinics 
who are more than 12 
months out from their 
transplant report they 
conduct total body skin 
self-examinations at 
least 6 times per year? 
Transplant Recipients Survey 
How could skin self-
examination education 
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Long-Term Objective 1: (Outcome Objective) 
 By year 3, all transplant clinics at UNC will use this program or a modified version of this 
program that includes regular and adequate education as well as an adequately regular and 
streamlined process for referring to dermatology.   
Evaluation Questions Participant Evaluation Method 
Do all transplant clinics at 
UNC use this program 
or a modified version 
of this program 
including adequate and 




Transplant Coordinators Document review: program 
documentation 
Open-ended interviews 
If any clinics are not using this 
program or a modified 
version of it, why not? 
Transplant Coordinators Open-ended interviews 
What challenges have 
transplant clinics faced 
in implementing this 
program?  
Transplant Coordinators Open-ended interviews, Focus 
groups 
If some clinics are using a 
modified version, how 
and why did they 
choose to modify it? 
Transplant Coordinators Open-ended interviews 
Is the program continuing to 
serve the needs of the 
transplant clinics? 
Transplant Coordinators Open-ended interviews, Focus 
groups, Surveys 
 
Long-Term Objective 2: (Process Objective) 
By year 3, communication will be established between UNC Dermatology and dermatology 
clinics across the state of North Carolina so that transplant patients can be followed by a 
dermatologist in their hometown if they prefer but tenets of the SCPI are still promoted at their 
clinic an  d UNC Dermatology remains a safety net. 
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Evaluation Questions Participant Evaluation Method 





across the state of 
North Carolina? 
Dermatology Clinic Staff Document review: program 
records, 
correspondence 
Is a list of dermatology clinics 
interested in caring for 
transplant patients 
compiled and readily 
available for reference 
during clinic 
appointments? 
Dermatology Clinic Staff Document review: program 
records 
Open-ended interviews 
Do collaborating clinics 
throughout the state 
know what the 
program entails and 
that UNC has a high-
risk clinic available if 
their transplant 




Clinics Throughout the 
State 
Surveys 





clinics and how could 
this process be 
improved? 




Long-Term Objective 3: (Outcome Objective) 
By year 5, obtain free or discounted sunscreen and hats for at least 75% of light-skinned 
transplant patients at participating clinics.  
Evaluation Questions Participant Evaluation Method 
By year 5, have free or 
discounted sunscreen 
and hats been obtained 
for at least 75% of 
Dermatology Clinic Staff Document review: program 
records 
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light-skinned 
transplant recipients at 
participating clinics? 
Has program staff met with 
Blue Cross Blue Shield 
about sunscreen and 
hat coverage? 
Program Coordinator Document review: meeting 
notes, calendar, emails 
Have hat manufacturers been 
contacted about 
providing free or 
discounted hats for all 
transplant patients on a 
one time basis? 
Program Coordinator Document review: program 
record, emails, letter 
drafts 
Have sunscreen manufacturers 
been contacted about 
providing free or 
discounted sunscreens 
for all transplant 
patients on a one time 
basis? 
Program Coordinator Document review: program 
record, emails, letter 
drafts 
Have businesses been 
contacted about 
donating a percentage 
of proceeds from a 
certain item towards 
providing sunscreen 
and hats for transplant 
patients? 
Program Coordinator Document review: program 
record, emails, letter 
drafts 
Have program staff identified 
and regularly applied 
for grants that could 
provide funding to 
purchase hats and 
sunscreen for 
transplant patients? 
Program Coordinator Document review: program 
record, emails, grant 
proposals 
Is the system of distribution of 
sunscreen and hats 
functional for the 
dermatology clinic and 
transplant patients?  
How could it be 
improved? 
Dermatology Clinic Staff, 
Transplant Recipients 
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Long-Term Objective 4: (Outcome Objective) 
By year 5, 40% of Caucasian transplant recipients will report always wearing a wide brim hat for 
outdoor activities and 60% of Caucasian transplant recipients will report applying adequately 
high SPF sunscreen at least 5 days per week year round prior to going outside.   
Evaluation Questions Participant Evaluation Method 
By year 5, what percentage of 
light-skinned 
transplant recipients 
report always wearing 
a wide brim hat for 
outdoor activities? 
Transplant Recipients Surveys 
By year 5, what percentage of 
light-skinned 
transplant recipients 
report using adequately 
high SPF sunscreen at 
least 5 days per week 
year round prior to 
going outside? 
Transplant Recipients Surveys 




Transplant Recipients, Family 
and Friends of 
Transplant Recipients 
Open-ended interviews, Focus 
groups, Surveys 
How could the program 
improve efforts to 
promote consistent use 
of hats and sunscreen 
among transplant 
recipients? 
Transplant Recipients Open-ended interviews, Focus 
groups, Surveys 
 
Long-Term Objective 5: (Outcome Objective) 
By year 5, a 20% reduction in invasive skin cancers will be observed among UNC transplant 
patients. 
Evaluation Questions Participant Evaluation Method 
By year 5, has a reduction in 
invasive skin cancers 
been observed among 
UNC transplant 
Transplant Clinic Staff 
Dermatology Clinic Staff 
Document review: transplant 
patient lists, electronic 
medical records 
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patients since the 
program was started? 
 
Dissemination 
 We will communicate evaluation results in several ways to ensure that stakeholders and 
other interested groups have the opportunity to learn from the findings.  Evaluation findings will 
be communicated with program staff throughout the evaluation process by using presentations 
and regular progress reports.  This will allow the Initiative to address identified areas for 
improvement as an iterative process and also ensure that evaluators continue to have all useful 
input for conducting a comprehensive and valuable evaluation.  At the end of the evaluation, we 
will produce a full, formal written report of the methods, results, and recommendations.  This 
will be disseminated to project staff, dermatology and transplant clinic staff, and funders.  To 
make the results and recommendations more accessible to these individuals, we will also use 
present the findings at meetings for the various clinics.   
 We will also share the results of the evaluation and recommendations with individuals 
not affiliated with the program, including both interested community or hospital groups and other 
dermatology and transplant clinics.  Information will be shared with community or hospital 
groups by presenting highlights of the most important findings at existing meetings and by 
creating a concise handout with an overview of the program and evaluation results.  The results 
and recommendations will be shared with other transplant and dermatology clinics by publishing 
a summary of the process and findings and by presenting at key national meetings for 
dermatologic and transplant societies.  By disseminating this information more widely, we hope 
to (a) create a guide for other clinics wishing to implement or modify a skin cancer prevention 
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program for transplant recipients and (b) help these programs achieve success by outlining the 
successes, challenges, and failures of the SCP Initiative.   
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V. DISCUSSION 
The development of skin cancer after organ transplantation is a growing problem due to 
increasing frequency of transplantation and improved survival after transplant
1,2
.  The 
prevalence
3-6
 and invasive nature
11-14
 of NMSC in transplant recipients constitute a substantial 
burden of suffering in this population, while management of these cancers incurs significant cost 
to transplant recipients and society
43
.   
Sun exposure, a primary risk factor for the development of NMSC after transplant, is 
modifiable.  Additionally, early detection through skin examination offers the possibility of 
removing skin cancers before they become invasive or require more aggressive therapies.  As a 
result, education and prevention efforts targeted towards transplant recipients could substantially 
reduce the burden of suffering due to skin cancer in this population.  Nonetheless, surveys have 
repeatedly demonstrated deficits in transplant recipients’ knowledge of skin cancer risk and 
prevention
22,23
 and UNC transplant clinic staff report poor transplant recipient attendance at 
recommended dermatology visits. 
The Skin Cancer Prevention Initiative, a program founded in behavioral change theory 
and modeled from previously successful skin cancer prevention programs, seeks to address an 
unfilled need for a collaborative and comprehensive skin cancer prevention program for UNC 
transplant recipients.  The primary goal of the program is to reduce the negative effect of skin 
cancer on quality of life and mortality for these individuals.  Key components of the program 
include developing a streamlined dermatology referral process, identifying individuals at the 
highest risk of skin cancer, and providing high quality skin cancer prevention education to 
transplant recipients through multiple sources.  Previous research suggests transplant recipients 
do not effectively absorb information about skin cancer risk for the first year after transplant
32
, 
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and the risk of sun damage is theoretically highest immediately after transplant, during the period 
of greatest immunosuppression.  Because of this, the SCP Initiative begins skin cancer 
prevention education while future transplant recipients are on the waitlist.  Additionally, the 
program attempts to reduce barriers to using sun protective behaviors by providing free hats and 
sunscreen to transplant recipients and by educating family members and close friends.   
The literature review of similar programs identified five skin cancer prevention programs 
that showed some promise of increasing use of sun protective behaviors or reducing the risk of 
skin cancer among the target population.  Because each program consisted of multiple 
components and evaluations assessed the programs as a whole, the value of individual program 
components could not be determined.  As a result, the SCP Initiative combines as many 
components as possible of each program while maintaining a relatively low budget and 
administrative burden due to incorporation of the program into existing clinic structures.   
A primary weakness of most of the reviewed programs was that the evaluation focused 
on short-term reported behavior change rather than more meaningful outcomes such as long-term 
behavior change or development of invasive skin cancer.  The evaluation plan for the SCP 
Initiative addresses a full range of outcomes from barriers to program implementation to 
development of skin cancer among participants at five years.  A full evaluation of the program 
offers the opportunity to advise others about what aspects of the program were successful and 
how similar programs could be implemented at other institutions.  It would also provide some of 
the first data regarding the effect of skin cancer prevention programs on skin cancer outcomes in 
transplant recipients.  If the evaluation ultimately demonstrates success at reducing the burden of 
skin cancer in this population, it would likely aid UNC and other institutions in obtaining 
funding for further transplant recipient skin cancer prevention efforts.  
 Moye 64 
 
Although the SCP Initiative is promising, its success hinges on several factors.  Without 
continued support from UNC’s transplant clinics and Department of Dermatology, the program 
could not be sustained.  Because the individuals in these departments who currently support the 
effort also have numerous other commitments, it will be important to ensure that some program 
staff have dedicated time to devote to program coordination and improvement.  Overall, the 
program should require relatively little time and effort for the health care providers who will be 
tasked with educating patients, conducting risk assessments, and maintaining the referral system.  
As a result, several key components of the program should be easy to implement and sustain.  
Nonetheless, obtaining grant support and establishing collaborations with insurance companies 
or sunscreen manufacturers could require substantial effort, as would full-scale evaluation.   
As the Initiative is primarily student-led at this time, a significant potential barrier to full-
scale program implementation and evaluation is whether grant support can be readily obtained.  
Grant support will be needed to support additional program staffing, and it would be difficult or 
impossible to conduct the program evaluation without sufficient funding.  Failure to conduct an 
evaluation would limit contributions to the greater body of knowledge about skin cancer 
prevention in transplant recipients and limit dissemination of the program to other institutions, 
even if the program is highly successful.  Additionally, a lack of evaluation would be a barrier to 
quality improvement efforts.  Continued quality improvement within the program will be 
important to ensure program acceptability to all stakeholders and make the program maximally 
effective.  Nonetheless, even if funding cannot be obtained, a partial version of the program that 
excludes full-scale evaluation and the provision of free hats and sunscreen may still do a great 
deal to meet the needs of UNC’s transplant recipient population.   
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brim hats and 
sunscreen with 










high risk of 






- Free sunscreen 
- Free wide brim 
hats 
- Cues to action 
(keychains, water 
bottles, and posters 




(elevated risk of 
skin cancer, sun 
protective behaviors, 
case report of a 





Comparison group:  
Delayed intervention 
group of post offices 
Methods:  
- Surveys of how often 
each individual used 
sunscreen and wide 
brim hats at 3 months, 
1 year, and 2 years 






At 2 years, 
intervention group 
participants were twice 
as likely to report 
always using sunscreen 
and 2.88 times as 
likely to report using 
wide brim hats 
In the intervention 
group, “all the time” 
sunscreen use 
increased from 27% to 
39% over 2 years and 
use of wide brim hats 
increased from 27% to 
40% 
Strengths:  
- Long follow-up 
- Multi-pronged 
approach 
- Validation of self-
reported measures 
Weaknesses: 
- No information 
about impact on skin 
cancer rates 
- Cannot identify 







































- Free sunscreen 
SPF >50 







Comparison group:  
Controls matched on 6 
different factors (age, 




malignancies or actinic 
keratoses) 
Evaluation:  
- At baseline and 24 
months, counted 
number of actinic 
keratoses, SCCs, and 
BCCS on areas of skin 
receiving daily 
sunscreen application 
- Sunscreen use diaries 
in intervention group 
- Validate reported 
sunscreen use with 
number of sunscreen 
bottles distributed 
Intervention group 
applied sunscreen an 
average of 5.6 times 
per week year round 
After 24 months, the 
control group had 82 
new actinic keratoses 
and had developed 8 
SCCs and 9 BCCs. 
The intervention group 
had regression of 102 
actinic keratoses and 
had developed no 
SCCs and 2 BCCs.   
The difference in 
actinic keratoses and 
SCCs between the two 
groups were 
statistically significant.  
Strengths:  
- Substantial reduction 
in most important 
outcomes of interest 
(development of 
cancer and precancer) 









- Unclear what 






training, or diary) was 
effective 

































2004 and April 
2005.  





- Detailed history 
and exam by 
dermatologist 
- Individualized risk 
of skin cancer 
- Counseling on sun 
protective measures 
 
Comparison group:  
Individuals who 
reported they had never 
been to the specialist 
dermatology clinic 
Evaluation:  
- Survey (dermatology 
clinic attendance, 
where received sun 
protection advise,  
nature of advice, sun 
protective measures 
used, why in need of 
extra sun protection) 
- Survey results 
combined with medical 
record data on time 
since transplant and 
history of skin cancer  
 
89% of respondents 
had attended the clinic 
at least once.  They 
had statistically 
significantly higher 
knowledge of skin 
cancer risk and use of 
sun protective 
behaviors.   
11% of survey 
respondents were non-
attenders.  They were 
statistically 
significantly different 
from attenders with 
regards to skin cancer 
history (no previous 
cancers) and shorter 
time since transplant.     
Strengths:  
- Individualized risk 
assessment 
Weaknesses*:  
- Extremely high 
potential for 
confounding due to 
significant differences  
between attenders and 
non-attenders 
- 27% survey non-
response 
 
*This is the only 
program reviewed that 
had a low quality 
evaluation, calling 
into question the 






























recipients at the 








- Packets of 
educational 
pamphlets at 2, 6, 
and 9 months after a 
standard clinic visit 
- Packets included 
information on sun 
protective measures, 





Comparison group:  
101 patients randomly 
assigned to control 
group 
Evaluation: 
- Baseline info 
collected through 
survey (knowledge, use 
of sun protective 
measures, intent to 
change, perceived 
barriers to change) 
- Follow-up 
questionnaires 
(knowledge, use of sun 
protective behaviors) at 
3 and 10 months 
At baseline, the 
intervention group 
reported more sun 
protective behaviors 
and higher intent to 
increase sun 
protection.  
Intervention group had 
higher increase in 
reported sun protection 
at 3 and 10 months. 
Control group had 
larger increases in SSE 
at 10 months.  
Substantial gap 
between knowledge 
and sun protective 
behaviors in both 
groups.  





model concepts  
- Randomization of 
participants 
- Assessment of both 
knowledge and 
behavior 
- Evaluation at 
multiple time points 
Weaknesses:  
- Baseline differences 
in sun protection and 






- No validation of 
self-report.  

























Island, NY, at 
moderate to 
high risk of 















 - Individual risk 
assessment using 
brief skin cancer 
risk assessment tool 
- Three packages 
sent in mail at 2-
week intervals: UV 
self-monitoring aids, 
instructions for SSE, 
and information 




- Single mailing 
with standard sun 
safety booklet, tip 
sheet on sunscreen 




randomized to control 
group 
Evaluation:  




and SSE behavior) at 
baseline and follow-up 
- Sun exposure diary (2 
weekdays and 2 
weekend days) 
- Telephone interviews 
(sun exposure and sun 
protective behaviors in 
previous week) at 
follow-up 
*Timing of follow-up 
not addressed in article 
Groups were 
comparable at baseline 
(no significant 
differences)  
Increase in sun 
protective behaviors 
and SSE in both 
groups (statistically 
significant).  
Reduction in sunburns 
and overall sun 
exposure in both 
groups (statistically 
significant).   
Greater (statistically 
significant) increase in 
sun protective 
behaviors and SSE in 
tailored group.  
Strengths: 
- Inclusion of people 
from geographically 
distinct locations 
- Large number of 
participants 
- Low cost per person 
- Multiple evaluation 
methods 
Weaknesses: 
- Low participation 
out of those eligible 
- No information 
about timing of 
follow-up evaluations  
- Cannot identify 
which components 
were effective 
- Evaluation based on 
self-report only 
 






























under the care 
of a 
dermatologist 
and without any 
history of skin 




between 1 and 
1.2 or 3 and 7 
years prior to 








- Mnemonic for 
SCC detection 
- Increased risk of 
skin cancer due to 
immunosuppressants 
- Importance of 
early detection of 
SCC 
- How to identify 
actinic keratoses 
- Worksheet to 
evaluate persona sun 
exposure 
- Assessment of 
personal SCC risk 










survey to both groups 





recognizing SCC, SSE 
behaviors, and 
likelihood of asking 
partners for assistance) 
- Repeated survey for 
intervention group after 
viewing workbook 
- Follow-up telephone 
interview at one month 
for both groups 
At baseline, groups 
similar but with 
differences in age and 
attitudes towards SSE.  
Repeat survey for 
intervention group 
found statistically 
significant increase in 
knowledge and 
attitudes favoring SSE. 
~3/4 who viewed 
workbook reported 
they were very likely 
to start SSE.   
At 1 month, 89% of 
intervention group and 
22% of control group 
reported checking skin 
since visit.  35% of 
intervention group 
participants who had 
conducted SSE since 
then found areas of 




high quality  methods 





- Measure at multiple 
time points 
- High participation 
rate 
- Identification of 
suspicious lesions 
Weaknesses: 
- Baseline age and 
attitude differences 
and lack of repeat 
survey in control 
group may confound 
results 
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0% in the control 
group.  
Rate of SSE was 
comparable between 
group 1-1.2 and 3-7 
years from transplant. 
Group who underwent 




suspicious areas during 
SSE.  
- Baseline differences 
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IX. Appendix B: Budget.  
SCPI 5-Year Budget       
         
PERSONNEL        
NAME TITLE APPT 
TYPE 
EFFORT DURATION BASE SALARY FRINGE TOTAL 
TBD Administrator 1 1 5 $10,000  $10,000  0 $50,000  
TBD Coordinator 1 0.5 1 $50,000  $25,000  $2,000  $27,000  
TBD Researcher 3 0.5 0.5 $45,000  $33,750  $3,000  $36,750  
      TOTAL  $113,750  
         
SUPPLIES        TOTAL 
Brochures and Educational Materials $3 per year per post-transplant patient $15,000  
Brochures and Educational Materials $3 every 5 years per pre-transplant patient $900  
Stamps    $5 every 5 years per pre-transplant patient $7,500  
Misc Printing and Office Supplies $500 per year   $2,500  
      TOTAL  $25,900  
         
DISCRETIONARY        
Unanticipated needs  $5000 per year   $25,000  
     TOTAL 5-YR PROGRAM COSTS $164,650  
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X. Appendix C. Ethical Considerations for the Institutional Review Board Application  
 In considering the ethics for evaluation of the SCP Initiative, several points must be 
addressed.  Understanding and minimizing the risk for human subjects involved in the evaluation 
is paramount.  The evaluation for the SCP Initiative will involve medical chart review as well as 
conducting surveys, open-ended interviews, and focus groups with patients.  These activities 
carry minimal risk to the participants as there is no potential for physical harm in this collection 
of observational data and we will be not be asking questions about sensitive subjects.   
 Confidentiality is also extremely important, particularly since evaluators will view 
patients’ medical records to determine rates of skin cancer development.  If any medical 
information was inadvertently exposed to individuals other than the evaluators, that would put 
the individual at risk and be a breach of confidentiality.  To address confidentiality concerns, we 
will de-identify all data at the time that it is recorded to minimize any risk that the individual’s 
information, should it inadvertently become available to someone other than the evaluator(s), 
could not be linked to that individual.  When seeking focus group and interview participants, we 
will use guidelines outlined in HIPAA to avoid sharing Personal Health Information with 
unauthorized individuals while contacting (potential) participants over the phone or through 
mailings.  Additionally, all evaluators will receive HIPAA authorization.  
 With the exception of the medical chart review, which does not require contacting the 
individuals, all participants will review and sign an informed consent document before 
participating.  This will need to be written at an appropriate reading level for our target 
population.  This will include a clear and complete description of the study, a description of 
foreseeable potential risks or benefits, and a statement of the extent to which confidentiality of 
the records will be maintained.  
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 In summary, we will take care to collect only the information needed for evaluation 
purposes, we will de-identify data at the time it is collected, and we will use a clear and complete 
informed consent process.  Due to the nature of the evaluation, there will be very minimal risk of 
any physical, emotional, or other type of harm.   Based on this, we will apply for an expedited 
IRB review. 
 
 
 
